A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less ...
Only myocarditis/pericarditis and seizures occurred at higher rates in adolescents and children vaccinated for COVID-19 when ...
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less ...
The original COVID-19 vaccines made by Pfizer and Moderna no longer are authorized in the U.S., the Food and Drug Administration announced on Tuesday, April 18. Now, both companies’ newer COVID ...
March 26, 2024 – The FDA has approved a new antibody treatment to help prevent COVID-19 in those who are most at risk from the virus. In its announcement, the agency explained that the new ...
Aiming to provide additional protection for Americans against the coronavirus over the upcoming flu season, the FDA authorized new versions of Pfizer and Moderna’s Covid-19 vaccines. WASHINGTON (CN) — ...
T he COVID vaccine may be linked to a small increase in stroke risk when given with a high-dose flu shot, primarily in ...
New, modified versions of Pfizer’s and Moderna’s existing COVID-19 vaccines received a green light from the Food and Drug Administration to be used as booster shots on Wednesday, Aug. 31.
Last fall, U.S. health officials authorized new COVID-19 booster shots designed to target the original strain of the coronavirus and some of the Omicron subvariants that were circulating around ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
Opinions expressed by Forbes Contributors are their own. I’m a virologist interested in pathogenesis and health disparities. In the continuing effort to mitigate the effects of Covid-19, the U.S ...
Brazilian drug regulator Anvisa on Monday (Jul. 24) gave its full approval for the bivalent Comirnaty COVID-19 vaccine by Pfizer. The jab is recommended for the prevention of COVID-19 and may now ...